All Stories

  1. New therapies for MEN2 disease

    Article • Endocrine Related Cancer, January 2018, Bioscientifica

    Luca Mologni

  2. Somatic mutations identified at diagnosis by exome sequencing can predict response to imatinib in chronic phase chronic myeloid leukemia (CML) patients

    Article • American Journal of Hematology, August 2017, Wiley

    Luca Mologni

  3. Efficacy of new inhibitors against drug-resistant ALK mutants

    Article • Cancer Medicine, February 2015, Wiley

    DILETTA FONTANA, Luca Mologni